Rockwell medical, inc. (RMTI)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash Flows From Operating Activities:
Net (Loss)

-

-

-

-

-

-

-

-

-

-

-

-

-4,742

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-7,983

-7,302

-7,855

-10,292

-8,678

-9,375

-4,969

-12,230

-5,549

-

-

-

-

-5,054

-4,563

-5,361

-4,824

-5,769

-2,414

-2,536

-3,699

-6,383

-3,967

-3,170

-7,805

-8,332

-13,208

-11,863

-15,379

-13,673

-17,875

-11,905

-10,566

-8,952

-5,041

-4,538

-2,912

Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities:
Depreciation and Amortization

209

206

201

192

187

183

185

152

129

129

125

128

130

178

187

195

200

214

199

200

207

228

260

248

257

255

250

251

250

258

273

277

277

247

277

320

329

Share Based Compensation - Non-employee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

427

234

234

966

1,012

694

329

285

-

-

-

-

Share Based Compensation - Non-employee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41

61

2

Stock-based Compensation

934

1,056

876

1,501

1,517

1,961

614

1,365

446

1,141

1,643

2,130

2,259

2,551

2,571

2,543

2,679

2,790

1,102

1,701

3,292

3,801

1,887

2,231

2,174

1,400

1,669

1,428

1,350

1,252

1,333

1,189

1,203

1,041

885

1,084

1,054

Increase in Inventory Reserves

0

0

1,079

181

11

5,341

-2,485

3,880

2,046

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of Right of Use Asset

390

434

453

497

478

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of Debt Financing Costs and Accretion of Debt Discount

15

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted Stock Tendered in Satisfaction of Tax Liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,449

-1,463

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on Disposal of Assets

-

-

-

-

-

-0

-1

0

-3

-6

-0

-0

-3

-0

-7

0

-0

-0

-1

0

-2

-2

0

-3

-1

-0

-9

-0

-5

8

-1

-14

-10

-1

-2

-19

-6

Amortization of Debt Issuance Costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

525

130

113

113

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash Interest Expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

520

128

112

112

-

-

-

-

-

-

-

-

-

-

-

-

Realized (Gain) on Sale of Investments Available-for-Sale

1

-

6

4

13

-

-97

-122

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign Currency Translation Adjustment

-5

0

0

-0

0

-3

6

4

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in Assets and Liabilities:
(Increase) Decrease in Accounts Receivable, net

384

-919

-266

-1,322

-268

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in Accounts Receivable

-

-

-

-

-

-

-

-

-295

812

493

-688

344

-1,821

441

1,366

1,176

-849

1,957

-727

193

282

-29

118

-477

355

-354

114

30

113

-37

140

-7

-35

-238

-190

180

Decrease in Insurance Receivable

0

0

0

0

-371

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Increase) Decrease in Inventory

827

-23

-227

96

-162

4,504

-2,358

-1,251

-59

-2,734

-141

241

2,291

2,207

750

1,845

1,292

456

1,100

1,119

1,275

938

197

-125

110

-14

-102

51

215

-22

-90

351

-93

269

-123

-424

-154

Decrease in Prepaid and Other Assets

-1,092

-

-

-

-203

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (Increase) in Other Assets

-

-

-

-

-

241

-766

929

-238

-40

124

-188

-160

-145

1,321

11

42

-653

675

112

226

-303

-2,076

2,149

243

-63

-77

-271

-257

-622

-473

-519

-240

-0

1,523

-1,391

2,325

Increase in Accounts Payable

104

-175

-871

-456

30

-2,439

3,724

-806

-209

32

319

-73

-1,914

2,461

-1,579

555

425

-1,228

903

-818

-156

123

-1,105

1,143

-3,552

1,574

-1,192

-7,796

1,266

6,742

1,679

1,749

-702

1,755

390

517

-958

Decrease in Settlement Payable

-47

-166

-160

263

-249

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in Lease Liability

-338

-

-392

-510

-467

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in Other Liabilities

737

696

-235

-2,312

1,319

2,381

-1,402

788

-1,494

1,497

-373

-2,650

2,160

370

-286

614

-507

845

537

-2,489

691

161

1,071

-1,788

-1,790

-3,216

1,587

-3,887

220

-3,354

4,501

1,834

848

2,314

2,314

132

266

Decrease in Deferred License Revenue

-446

-563

-563

-563

-563

-675

-572

-1,718

572

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Decrease) in Deferred License Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-498

-620

-481

-481

-481

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in deferred drug license revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-68

-68

3,954

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred License Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-493

-493

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in Assets and Liabilities

108

-304

923

2,431

-1,074

4,998

-1,783

-1,465

1,683

-2,862

1,233

2,586

2,727

-2,860

4,929

2,603

-878

-62

2,784

4,305

1,653

-18,859

-1,874

2,787

5,219

1,919

-928

11,577

-1,498

-3,919

-6,782

-3,609

-488

-3,836

-1,543

-2,656

3,043

Cash Used In Operating Activities

-6,538

-5,300

-6,175

-10,354

-5,423

-5,784

-4,778

-5,249

-4,607

-4,810

-4,184

-7,040

-5,076

537

-6,695

-5,229

-1,065

211

-3,836

-6,389

-3,313

17,555

313

-3,246

-10,365

-8,142

-9,687

-21,526

-11,307

-7,170

-8,790

-6,483

-8,301

-3,533

-2,291

-396

-4,561

Cash Flows From Investing Activities:
Purchase of Investments Available-for-Sale

8,871

-

-

-

8,812

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of Investments Available-for-Sale

-

-

-

-

-

-1,694

-15,889

-1,177

-1,416

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of Securities Available for Sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,100

0

0

2,000

-

-

-

-

-

-

-

-

1,975

-134

77

81

Sale of Investments Available-for-Sale

11,660

7,786

11,680

6,037

12,761

4,299

23,463

5,082

1,050

11,796

6,770

33,320

31

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of Equipment

202

138

143

183

121

154

248

185

155

976

305

239

162

26

99

26

202

478

128

130

77

71

184

98

329

157

183

159

153

126

138

153

88

76

133

89

121

Purchase of Research and Development Licenses (Related Party)

0

0

250

250

250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds on Sale of Assets

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

0

0

0

4

-

-

-

-

0

0

0

5

0

0

1

0

-

-

-

0

Cash Provided By Investing Activities

2,586

172

-1,141

-7,357

3,576

2,200

7,324

3,719

-521

9,321

-507

5,818

-130

-2,649

2,164

-956

-202

-478

-159

-20,430

-72

-11,171

-184

4,877

-2,329

-2,159

-10,183

-158

-147

10,461

3,297

-2,152

-88

-74

-143

-167

-202

Cash Flows From Financing Activities:
Proceeds from Term Loan

22,500

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the Issuance of Common Shares and Purchase Warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2

0

77

-

-

-

-

76,934

593

567

1,474

970

161

37,944

12,518

247

198

1,468

16,317

-

-

-

-

Debt Issuance Costs

374

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on Short Term Note Payable

572

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

3

2

4

4

6

Proceeds from the Issuance of Common Stock / Public Offering

8,147

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

633

918

-

-

-

-

-

-

-

-

-

-

-

-

-

1,542

1,933

459

Offering Costs from the Issuance of Common Stock / Public Offering

143

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the Exercise of Employee Stock Options

0

0

0

0

147

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of Common Shares to Pay Employee Withholding Taxes

0

-99

-275

0

95

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Provided By Financing Activities

29,557

2,501

320

18,209

52

-

-

-

-

-

-

-

-

0

2

0

77

-1,708

23

633

918

56,399

28

567

1,474

970

132

56,862

12,517

246

197

1,466

16,314

902

1,538

1,929

453

Increase (Decrease) In Cash and Cash Equivalents

25,605

-

-6,995

497

-1,794

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effects of Exchange Rate Changes

-

-

-

-

-

-

-

-

-

-

0

-0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease In Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-5,128

4,518

-4,576

-3,509

-5,206

-2,112

-4,528

-6,185

-1,190

-1,974

-3,973

-26,186

-2,467

62,783

158

2,197

-11,220

-9,331

-19,739

35,177

1,062

3,537

-5,295

-7,169

7,924

-2,706

-896

1,365

-4,311

Supplemental Disclosure of Cash Flow Information:
Cash Paid for Interest

80

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental Disclosure of Noncash Investing and Financing Activities:
Change in Unrealized Loss on Marketable Securities Available-for-Sale

-6

-

-

2

-7

-

-

237

-189

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Delivery of Common Stock Underlying Restricted Stock Units

0

-

-

-

273

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance Costs related to Debt Financing, not yet paid

956

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair Value of Warrants issued related to Debt Financing

500

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest Paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

404

-

-

-

-

1,612

638

638

628

631

520

1

0

0

0

0

0

0

0

0

0